youtube_live
Q3 2026 earnings • in 1 day
See detailschevron_right
CDXS:NASDAQ
Codexis Inc
$1.00
arrow_downward
-9.91%(-0.11) 1D
$1.02
arrow_upward
+1.91% (+0.019)bedtimeAfter hours
Closed: Nov 10, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CDXS...
Open
$1.12
High
$1.14
Low
$1.00
Mkt. cap
109.51M
Avg. vol.
822.99K
Volume
2.00
52-wk high
$2.98
52-wk low
$0.96
EPS
-$0.34
Beta
2.38
Shares outstanding
109.51M
No. of employees
146
Open
$1.12
High
$1.14
Low
$1.00
Mkt. cap
109.51M
Avg. vol.
822.99K
Volume
2.00
52-wk high
$2.98
52-wk low
$0.96
EPS
-$0.34
Beta
2.38
Shares outstanding
109.51M
No. of employees
146
News stories
From web sources and news partners
TradingView
·
13 hours ago
Codexis, Inc. expected to post a loss of 10 cents a share - Earnings Preview
Zacks
·
22 hours ago
Opus Genetics, Inc. (IRD) Reports Q3 Loss, Lags Revenue Estimates
Quantisnow
·
23 hours ago
CDXS: Codexis Inc. filed SEC Form 8-K: Entry into a Material...
Investing.com
·
1 day ago
Codexis secures $60M term loan from Trinity Capital
Profile
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
About Codexis Inc
CEOJohn Nicols
Employees146
Founded2002
HeadquartersRedwood City, California, United States
SectorHealth Care
Industry-
Websitecodexis.com